Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review-Reference-Cited by-同舟云学术

Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review

Published:2024-06-01 Issue:5 Volume:37 Page:221-239
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Nikmanesh Nika¹,Hosseini SeyedehZahra²^ORCID,Mirbagheri Fatemehsadat¹,Asadsangabi Kimiya¹,Fattahi Mohammad Reza¹,Safarpour Ali Reza¹,Abarghooee Ebrahim Fallahzadeh³,Moravej Ali⁴,Shamsdin Seyedeh Azra¹,Akrami Hassan¹,Saghi Seyyed Amirreza⁵⁶,Nikmanesh Yousef¹^ORCID

Affiliation:

1. Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

2. Department of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Iran.

3. Department of Internal Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

4. Department of Laboratory Sciences, School of Allied Medical Sciences, Fasa University of Medical Science, Fasa, Iran.

5. Cellular and Molecular Biology Research Center, Larestan University of Medical Sciences, Larestan, Iran.

6. Student Research Committee, Faculty of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2023.0144

Reference124 articles.

1. Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?

2. Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State

3. Role of Innate Immunity against Human Papillomavirus (HPV) Infections and Effect of Adjuvants in Promoting Specific Immune Response

4. Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV

5. A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities